Cedars Sinai gets 30M to establish a specialized BRCA cancer center focusing on research, diagnosis, and treatment in Los Angeles.

The U.S. Food and Drug Administration has granted regular approval to treatment with Rubraca (rucaparib) for the treatment of ...

However, many women with BRCA mutations perceive MHT as unsafe, due to concerns about their already elevated breast cancer ...

Kotsopoulos noted that BRCA carriers have a substantially increased lifetime risk of breast and ovarian cancer. Management of ...

Germline BRCA mutations have an adverse impact on both progression-free and overall survival in patients with hormone receptor-positive/HER2-negative metastatic ...

An affordable new BRCA gene test has hit the market, but who should take it? — -- A new genetic testing kit that hits the market today is the most affordable, and arguably one of the simplest, ...

SAN ANTONIO – Patients with germline BRCA mutations who were diagnosed with breast cancer at or before age 40 and who underwent a bilateral risk-reducing mastectomy (RRM) and/or a risk-reducing ...

NEW YORK, Feb 24 (Reuters) - Women with genetic mutations that increase their risk of ovarian cancer have fewer years than physicians thought to make the difficult choice of having their ovaries ...

Younger age at diagnosis did not appear to affect outcomes among women with breast cancer who harbor BRCA mutations, ...

VANESSA THANK YOU. AND NOW TO THE STORY OF A WOMAN WHO IS NOT ONLY A BREAST CANCER ADVOCATE, SHE’S AN AUTHOR AND NOW A MOVIE PRODUCER. HER FIRST FULL LENGTH FILM TACKLES THE DECISIONS A WOMAN WITH A ...

Women who used estrogen had a significantly lower risk for breast cancer compared with unexposed matched controls.